• One Health
  • Pain Management
  • Oncology
  • Anesthesia
  • Geriatric & Palliative Medicine
  • Ophthalmology
  • Anatomic Pathology
  • Poultry Medicine
  • Infectious Diseases
  • Dermatology
  • Theriogenology
  • Nutrition
  • Animal Welfare
  • Radiology
  • Internal Medicine
  • Small Ruminant
  • Cardiology
  • Dentistry
  • Feline Medicine
  • Soft Tissue Surgery
  • Urology/Nephrology
  • Avian & Exotic
  • Preventive Medicine
  • Anesthesiology & Pain Management
  • Integrative & Holistic Medicine
  • Food Animals
  • Behavior
  • Zoo Medicine
  • Toxicology
  • Orthopedics
  • Emergency & Critical Care
  • Equine Medicine
  • Pharmacology
  • Pediatrics
  • Respiratory Medicine
  • Shelter Medicine
  • Parasitology
  • Clinical Pathology
  • Virtual Care
  • Rehabilitation
  • Epidemiology
  • Fish Medicine
  • Diabetes
  • Livestock
  • Endocrinology

Entest signs letter of intent to buy three more animal hospitals

Article

San Diego - Entest BioMedical, a company developing an immunotherapeutic cancer treatment for dogs, signed a letter of intent to buy three veterinary hospitals in Orange County.

SAN DIEGO— Entest BioMedical, a company developing an immunotherapeutic cancer treatment for dogs, signed a letter of intent to buy three veterinary hospitals in Orange County.

The company reports the acquisition will generate about $900,000 in new revenue and will help the company execute on its strategic goal of creating a network of animal hospitals, In January, the company closed on the purchase of Santa Barbara's McDonald Animal Hospital. These acquisitions are estimated at bringing Entest revenues of about $2 million a year in the veterinary hospital segment.

"Initially, Entest plans on focusing on veterinary acquisition candidates in California, with future plans to expand into other states," company officials say.

Last November, Entest unveiled a safety study for an immunotherapeutic cancer vaccine for dogs currently in development. Entest also initiated a collaboration with RenovoCyte LLC and Medistem Inc. to explore the development of a stem-cell therapy for treating hip dysplasia in dogs.

Related Videos
Innovators
Senior Bernese Mountain dog
© 2024 MJH Life Sciences

All rights reserved.